Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
Go back to Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial| (NASDAQ: MDXH) | Delayed: 0.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.40 | 52 Week High | $ | |||
| Open | $0.40 | 52 Week Low | $ | |||
| Day High | $0.40 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $ | |||
| Volume | 303 | |||||

